Uae Regulatory Affairs Outsourcing Market Size & Outlook
The regulatory affairs outsourcing market in the UAE is expected to reach a projected revenue of US$ 60.7 million by 2030. A compound annual growth rate of 2.6% is expected of the UAE regulatory affairs outsourcing market from 2024 to 2030.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, South Africa regulatory affairs outsourcing market is projected to lead the regional market in terms of revenue in 2030.
South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 103.0 million by 2030.
Currently, UAE is the third largest market for Regulatory affairs in the MEA region since most market players are dependent on imports. Medical device regulations in the country are based on Australian TGA, EU, and the U.S. regulations.
Products with approval from the Canadian, Australian, EU, and the U.S. regulatory agencies are eligible for a short registration process in the UAE. The UAE Government is focused on attracting innovative drug manufacturers by 2021, with double the number of local companies producing patented drugs.
The country has a short drug registration system for both innovator and generic drugs approved by the U.S. FDA. Some of the examples of fast-tracked drugs in UAE are AbbVie’s Viekirax, Exviera (dasabuvir), and Eli Lilly's Trulicity.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Regulatory Affairs Outsourcing Market Outlook will help companies and investors design strategic landscapes.
Product Registration & Clinical Trial Applications was the largest segment with a revenue share of 26.04% in 2023.
Horizon Databook has segmented the Uae regulatory affairs outsourcing market based on regulatory consulting, legal representation, regulatory writing & publishing, product registration & clinical trial applications, regulatory submissions, regulatory operations, other services covering the revenue growth of each sub-segment from 2018 to 2030.
Currently, UAE is the third largest market for Regulatory affairs in the MEA region since most market players are dependent on imports. Medical device regulations in the country are based on Australian TGA, EU, and the U.S. regulations.
Products with approval from the Canadian, Australian, EU, and the U.S. regulatory agencies are eligible for a short registration process in the UAE. The UAE Government is focused on attracting innovative drug manufacturers by 2021, with double the number of local companies producing patented drugs.
The country has a short drug registration system for both innovator and generic drugs approved by the U.S. FDA. Some of the examples of fast-tracked drugs in UAE are AbbVie’s Viekirax, Exviera (dasabuvir), and Eli Lilly's Trulicity.
Uae Regulatory Affairs Outsourcing Market Service Outlook (Revenue, USD Million , 2018-2030)
Uae Regulatory Affairs Outsourcing Market Category Outlook (Revenue, USD Million , 2018-2030)
Drugs
Biologics
Medical Devices
Uae Regulatory Affairs Outsourcing Market End-User Outlook (Revenue, USD Million , 2018-2030)
Biotechnology Companies
Pharmaceutical Companies
Medical Device Companies
Uae Regulatory Affairs Outsourcing Market Company Size Outlook (Revenue, USD Million , 2018-2030)
Small
Medium
Large
Uae Regulatory Affairs Outsourcing Market Indication Outlook (Revenue, USD Million , 2018-2030)
Oncology
Neurology
Cardiology
Immunology
Others
Uae Regulatory Affairs Outsourcing Market Stage Outlook (Revenue, USD Million , 2018-2030)
Preclinical
Clinical studies
PMA
Reasons to subscribe to Regulatory Affairs Outsourcing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Regulatory Affairs Outsourcing Market Outlook databook
Our clientele includes a mix of Regulatory Affairs Outsourcing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE Regulatory Affairs Outsourcing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into UAE Regulatory Affairs Outsourcing Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.